Does Eloxx Pharmaceuticals Inc (ELOX) Have What it Takes to be in Your Portfolio Friday?

Friday, September 16, 2022 12:08 PM | InvestorsObserver Analysts

Mentioned in this article

Does Eloxx Pharmaceuticals Inc (ELOX) Have What it Takes to be in Your Portfolio Friday?

A rating of 42 puts Eloxx Pharmaceuticals Inc (ELOX) near the middle of the Biotechnology industry according to InvestorsObserver. Eloxx Pharmaceuticals Inc's score of 42 means it scores higher than 42% of stocks in the industry. Eloxx Pharmaceuticals Inc also received an overall rating of 51, putting it above 51% of all stocks. Biotechnology is ranked 19 out of the 148 industries.

ELOX has an Overall Score of 51. Find out what this means to you and get the rest of the rankings on ELOX!

See Full ELOX Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 51 means the stock is more attractive than 51 percent of stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Eloxx Pharmaceuticals Inc Stock Today?

Eloxx Pharmaceuticals Inc (ELOX) stock is flat -0.98% while the S&P 500 has fallen -1.24% as of 12:06 PM on Friday, Sep 16. ELOX is unmoved $0.00 from the previous closing price of $0.22 on volume of 357,826 shares. Over the past year the S&P 500 is down -13.87% while ELOX has fallen -87.43%. ELOX lost -$0.51 per share the over the last 12 months. Click Here to get the full Stock Report for Eloxx Pharmaceuticals Inc stock.